These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 31593159)

  • 21. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
    Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
    Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iron in kidney and heart failure: from theory to practice.
    Yerlikaya A; Bulbul MC; Afsar B; Dagel T; Aslan G; Voroneanu L; Siriopol D; Covic A; Kanbay M
    Int Urol Nephrol; 2018 Mar; 50(3):481-493. PubMed ID: 28940112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A circular transcript of
    Li M; Ding W; Tariq MA; Chang W; Zhang X; Xu W; Hou L; Wang Y; Wang J
    Theranostics; 2018; 8(21):5855-5869. PubMed ID: 30613267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. cGMP-Elevating Compounds and Ischemic Conditioning Provide Cardioprotection Against Ischemia and Reperfusion Injury via Cardiomyocyte-Specific BK Channels.
    Frankenreiter S; Bednarczyk P; Kniess A; Bork NI; Straubinger J; Koprowski P; Wrzosek A; Mohr E; Logan A; Murphy MP; Gawaz M; Krieg T; Szewczyk A; Nikolaev VO; Ruth P; Lukowski R
    Circulation; 2017 Dec; 136(24):2337-2355. PubMed ID: 29051185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation and treatment for iron deficiency in heart failure: the unmet need in Lower and Middle Income Countries.
    Makubi A; Roberts DJ
    Br J Haematol; 2017 Jun; 177(6):896-904. PubMed ID: 28568509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron deficiency in heart failure: Efficacy and safety of intravenous iron therapy.
    Kang CK; Pope M; Lang CC; Kalra PR
    Cardiovasc Ther; 2017 Dec; 35(6):. PubMed ID: 28836730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anemia in heart failure: association of hepcidin levels to iron deficiency in stable outpatients.
    Weber CS; Beck-da-Silva L; Goldraich LA; Biolo A; Clausell N
    Acta Haematol; 2013; 129(1):55-61. PubMed ID: 23147477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The iron-regulatory peptide hepcidin is upregulated in the ischemic and in the remote myocardium after myocardial infarction.
    Simonis G; Mueller K; Schwarz P; Wiedemann S; Adler G; Strasser RH; Kulaksiz H
    Peptides; 2010 Sep; 31(9):1786-90. PubMed ID: 20553779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell death, tissue hypoxia and the progression of heart failure.
    Sabbah HN; Sharov VG; Goldstein S
    Heart Fail Rev; 2000 Jun; 5(2):131-8. PubMed ID: 16228140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiomyocyte death and renewal in the normal and diseased heart.
    Buja LM; Vela D
    Cardiovasc Pathol; 2008; 17(6):349-74. PubMed ID: 18402842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepcidin and disorders of iron metabolism.
    Ganz T; Nemeth E
    Annu Rev Med; 2011; 62():347-60. PubMed ID: 20887198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anemia as a risk factor for ischemic heart disease.
    Zeidman A; Fradin Z; Blecher A; Oster HS; Avrahami Y; Mittelman M
    Isr Med Assoc J; 2004 Jan; 6(1):16-8. PubMed ID: 14740503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Quality of life and iron metabolism in patients with anemic syndrome developed on the background of chronic heart failure].
    Ryndina N; Kravchun P; Tytova G
    Georgian Med News; 2013 Mar; (216):16-9. PubMed ID: 23567302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heart failure in patients with kidney disease and iron deficiency; the role of iron therapy.
    Cases Amenós A; Ojeda López R; Portolés Pérez JM;
    Nefrologia; 2017; 37(6):587-591. PubMed ID: 28610806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia-driven sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) downregulation depends on low-density lipoprotein receptor-related protein 1 (LRP1)-signalling in cardiomyocytes.
    Revuelta-López E; Cal R; Herraiz-Martínez A; de Gonzalo-Calvo D; Nasarre L; Roura S; Gálvez-Montón C; Bayes-Genis A; Badimon L; Hove-Madsen L; Llorente-Cortés V
    J Mol Cell Cardiol; 2015 Aug; 85():25-36. PubMed ID: 25968337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anemia and iron deficiency in heart failure.
    Gil VM; Ferreira JS
    Rev Port Cardiol; 2014 Jan; 33(1):39-44. PubMed ID: 24216080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Iron deficiency and digestive disorders].
    Cozon GJ
    Transfus Clin Biol; 2014 Nov; 21(4-5):189-92. PubMed ID: 25282486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of Fas in the progression of ischemic heart failure: prohypertrophy or proapoptosis.
    Feng QZ; Zhao YS; Abdelwahid E
    Coron Artery Dis; 2008 Nov; 19(7):527-34. PubMed ID: 18923250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives.
    Jankowska EA; von Haehling S; Anker SD; Macdougall IC; Ponikowski P
    Eur Heart J; 2013 Mar; 34(11):816-29. PubMed ID: 23100285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iron Deficiency Treatment in Patients with Heart Failure.
    Jankowska EA; Drozd M; Ponikowski P
    Handb Exp Pharmacol; 2017; 243():561-576. PubMed ID: 28405775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.